Alicia Gilsenan

RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Search Publications

Filter by Year

Filter by Publication Type

Filter by Publication Topic

Search Results

Physician awareness of the safe use of cyproterone acetate in Europe: A survey on the effectiveness of additional risk minimization measures

Post-authorization safety studies of acute liver injury and severe complications of urinary tract infections in patients with type 2 diabetes exposed to dapagliflozin in a real-world setting

Post-authorization safety study of hospitalization for acute kidney injury in patients with type 2 diabetes exposed to dapagliflozin in a real-world setting

Risk of major cardiovascular and cerebrovascular events in users of Lisdexamfetamine and other medications for attention-deficit/hyperactivity disorder in Denmark and Sweden: A population-based cohort study

Adapting to the dynamic landscape of the COVID-19 pandemic: Proposed study design approaches for a postauthorization safety study for Pfizer-BioNTech COVID-19 vaccine in the United States

Capacity for identifying Janssen Ad26.COV2.S COVID-19 vaccination in four US health insurance and state Immunization Information System databases: preparation for a post authorization safety study

Identification and validation of major cardiovascular events in the United Kingdom data sources Included in a multi-database post-authorization safety study of prucalopride

Teriparatide did not increase adult osteosarcoma incidence in a 15-year US postmarketing surveillance study

Validation of cardiovascular outcomes and risk factors in the Clinical Practice Research Datalink in the United Kingdom

Assessing the incidence of osteosarcoma among teriparatide users based on Medicare Part D and US State Cancer Registry Data

No evidence of off-label use of olodaterol and indacaterol in Denmark, France, and the Netherlands: A drug utilization study

Validity of claims-based algorithms to identify acute kidney injury, acute liver injury, severe complications of urinary tract infections, breast cancer, and bladder cancer among patients with type 2 diabetes: A pilot study

Predictors of response outcomes for research recruitment through a central cancer registry: Evidence from 17 recruitment efforts for population-based studies

The experience of accommodating privacy restrictions during implementation of a large-scale surveillance study of an osteoporosis medication

Long-Term Cancer Surveillance: Five-Year Update for the Forteo Patient Registry Surveillance Study (Meeting Abstract

Forteo Voluntary Patient Registry: 4-Year Progress on A Prospective Osteosarcoma Surveillance Study

Risk evaluation and mitigation strategy assessments: Social science methodologies to assess goals related to knowledge

The US postmarketing surveillance study of adult osteosarcoma and teriparatide: Study design and findings from the first 7 years

Prevalence of airway obstruction assessed by lung function questionnaire

Application of the BRAT framework to case studies: Observations and insights